Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

135 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer Surgery

NCT06263205

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +14 more
Locations
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Changzheng Hospital, Navy Medical University Shanghai, Shanghai Municipality, China
  • Shanghai East Hospital, School of Medicine, Tongji University Shanghai, Shanghai Municipality, China
  • Changhai Hospital, Naval Medical University Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Drainage After Rectal Excision for Rectal Cancer

NCT01269567

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
Locations
  • CHU d'AMIENS Amiens, France
  • CH de BEAUVAIS Beauvais, France
  • Service de Chirurgie Digestive - Hôpital Saint-André - CHU de Bordeaux Bordeaux, France
  • Service de Chirurgie Générale et Digestive - Hôpital Beaujon Clichy, France
View all 22 locations
View Trial Details
Completed

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

NCT05039177

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
Locations
  • University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California Irvine College of Medicine Orange, California, United States
  • UCSF Mount Zion Medical Ctr San Francisco, California, United States
View all 14 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors

NCT04774952

Conditions
Adnexal Diseases, Bronchial Diseases, Bronchial Neoplasms, +63 more
Locations
  • UC Irvine - Chao Family Comprehensive Cancer Center Irvine, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Francisco - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions